Antimicrobial Peptides Against Antibiotic Resistance: A Key Direction in the Global Anti-Infective Market
As antibiotic resistance continues to worsen worldwide, the pharmaceutical industry is searching for next-generation anti-infective…
News
Eli Lilly’s Imlunestrant Approved in China: Oral SERD Offers a New Treatment Option for ESR1-Mutated Breast Cancer
On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Eli Lilly’s innovative…
What Are the Signs of Liver Cancer Getting Worse? Symptoms of Advanced Liver Cancer
Liver cancer is one of the most serious and life-threatening cancers worldwide. According to the…
Silevimig Approved for Rabies Passive Immunization: The First Approved Bispecific Antibody for Rabies Prevention Worldwide
On June 22, 2026, China’s National Medical Products Administration (NMPA) officially approved Silevimig Injection (Jinsuxi®),…
Oral GLP-1 Drug Development Trends: Small-Molecule Innovation and Industry Competition
In recent years, GLP-1 receptor agonists (GLP-1 RAs) have become one of the most closely…
RNA Therapeutics for Cardiovascular Disease: PCSK9, Lp(a) and Next-Gen Drug Pipeline (2026)
RNA therapeutics for cardiovascular disease are emerging as a transformative strategy for long-term disease management.…
China Approves the World’s First CAR-T Therapy for Solid Tumors: Satricabtagene Autoleucel for CLDN18.2-Positive Advanced Gastric Cancer
On June 22, 2026, China’s National Medical Products Administration (NMPA) approved Satricabtagene Autoleucel (Kailimei®), developed…
10 Key Questions Cancer Patients Ask: From Survival Rates to Treatment Options
Cancer treatment is often a long and uncertain journey. Global pharmaceutical distributor DengYueMed has organized…
Izalontamab Brengitecan Approved in China: World’s First EGFR×HER3 Bispecific ADC, a Breakthrough in Nasopharyngeal Cancer
On June 22, 2026, NMPA officially approved Biokin Pharmaceutical’s independently developed Class 1 innovative drug,…
China API Industry Overview: Key Strength Areas, Supply Chain Capabilities, and Global Market Position
Over the past two decades, the China API industry has evolved into a foundational pillar…